These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 140943)

  • 1. Multicellular spheroids: a new model target for in vitro studies of immunity to solid tumor allografts.
    Sutherland RM; MacDonald HR; Howell RL
    J Natl Cancer Inst; 1977 Jun; 58(6):1849-53. PubMed ID: 140943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multicellular spheroid as a model tumor allograft. I. Quantitative assessment of spheroid destruction in alloimmune mice.
    MacDonald HR; Howell RL
    Transplantation; 1978 Mar; 25(3):136-40. PubMed ID: 644649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The multicellular spheroid as a model tumor allograft. II. Characterization of spheroid-infiltrating cytotoxic cells.
    MacDonald HR; Howell RL; McFarlane DL
    Transplantation; 1978 Mar; 25(3):141-5. PubMed ID: 306146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of in situ host immunity to syngeneic tumors utilizing the multicellular spheroid model.
    Lord EM; Burkhardt G
    Cell Immunol; 1984 May; 85(2):340-50. PubMed ID: 6713544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of in situ and peripheral host immunity to syngeneic tumours employing the multicellular spheroid model.
    Lord EM
    Br J Cancer Suppl; 1980 Apr; 4():123-7. PubMed ID: 6932915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.
    Kedar E; Bonavida B
    J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediation of immune responses to tumor antigens in vitro by immune RNA.
    Kern DH; Drogemuller CR; Pilch YH
    Ann N Y Acad Sci; 1976; 276():278-302. PubMed ID: 1071964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immunoabsorbents in transplantation immunity. Specific in vitro deletion and recovery of mouse lymphoid cells sensitized against allogeneic tumors.
    Berke G; Levey RH
    J Exp Med; 1972 Apr; 135(4):972-84. PubMed ID: 4622914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rejection of tumor allografts by mouse spleen cells sensitized in vitro.
    Cohen IR; Globerson A; Feldman M
    J Exp Med; 1971 Apr; 133(4):821-33. PubMed ID: 5547058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incompatibility at irrelevant H-2 specificities augments in vivo stimulation of alloaggressive cells.
    Jorgensen PN
    Scand J Immunol; 1975; 4(4):373-82. PubMed ID: 52889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A micro-colony-inhibition method for quantitation of tumor immunity.
    Haskill JS
    J Natl Cancer Inst; 1973 Nov; 51(5):1581-8. PubMed ID: 4762935
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro detection of cytotoxic cellular immunity against tumor-specific antigens by a radioisotopic technique.
    Jagarlamoody SM; Aust JC; Tew RH; McKhann CF
    Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1346-50. PubMed ID: 4331089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific stimulatory and cytotoxic effects of lymphocytes sensitized in vitro to either alloantigens or tumor antigens.
    Kall MA; Hellström I
    J Immunol; 1975 Mar; 114(3):1083-8. PubMed ID: 1112984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The multicellular tumor spheroid model. II. Characterization of the primary allograft response in unsensitized mice.
    Lord EM; Nardella G
    Transplantation; 1980 Feb; 29(2):119-24. PubMed ID: 6766584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro induction of tumor-specific immunity. I. Parameters of activation and cytotoxic reactivity of mouse lymphoid cells immunized in vitro against syngeneic and allogeneic plasma cell tumors.
    Wagner H; Röllinghoff M
    J Exp Med; 1973 Jul; 138(1):1-15. PubMed ID: 4541509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
    Plata F; Jongeneel V; Cerottini JC; Brunner KT
    Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H-2 private specificity of in vivo-sensitized lymphocytes studied by adsorption on fibroblast monolayers.
    Jorgensen PN; Güttler F; Rubin B
    Scand J Immunol; 1975; 4(4):383-9. PubMed ID: 52890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell-mediated immunity to antigens associated with murine sarcoma virus-induced tumors: augmentation of cytolytic T lymphocyte activity by successive specific and nonspecific stimulation in vitro.
    Ryser JE; Cerottini JC; Brunner KT
    Eur J Immunol; 1979 Mar; 9(3):179-84. PubMed ID: 221224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro studies on cell-mediated cytotoxicity by means of a terminal labeling technique.
    More R; Yron I; Sasson SB; Weiss DW
    Cell Immunol; 1975 Feb; 15(2):382-91. PubMed ID: 122915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.